Eastern Canadian Colorectal Cancer Consensus Conference: Standards of Care for the Treatment of Patients with Rectal, Pancreatic, and Gastrointestinal Stromal Tumours and Pancreatic Neuroendocrine Tumours
T. Di Valentin(Sunnybrook Health Science Centre), Rachel Goodwin(University of Ottawa), P. Champion(Royal Marsden Hospital), Rakesh Goel(Ottawa Hospital), V. Chaput(McGill University Health Centre), James Biagi(Queen's University), Michael P. Thirlwell(McGill University Health Centre), Brian Colwell, Cindy Quinton(Sunnybrook Health Science Centre), Frances C. Wright(Saint John's Health Center), Stephen Welch(Cancer Care Ontario), Stephanie Snow(Dalhousie University), M. Nantais(McGill University Health Centre), Alwin Jeyakumar(Queen Elizabeth II Health Sciences Centre), Conrad Falkson(Sunnybrook Health Science Centre), Ève St‐Hilaire(Dr. Georges-L.-Dumont University Hospital Centre), Nazik Hammad(St. Michael's Hospital), Sharlene Gill(Deventer Ziekenhuis), Mustapha Tehfé(Centre Hospitalier de l’Université de Montréal), C. Cripps(Canadian Partnership Against Cancer), Mary Lesperance(University of Victoria), Dominique Frechette, Celia Marginean(Sunnybrook Health Science Centre), Nancy Perrin(Oregon Health & Science University), Simron Singh(Sunnybrook Health Science Centre), L. Williams, M. Dorreen(Saint John Regional Hospital), Susan Bourque(BC Cancer Agency), Benoît Samson(Hôpital Charles-Le Moyne), Jean A. Maroun(American Society of Clinical Oncology), J. Siddiqui(Dr. H. Bliss Murphy Cancer Centre), DeloresJ Grant(Dalhousie University), M. Rother(Credit Valley Hospital), S. Edwards(Leonard Cheshire), Roeum Butt(Mount Vernon Cancer Centre)
Cited by 5
Related Papers
Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer
|New England Journal of Medicine|2000|3k
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.9k
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
|Journal of Clinical Oncology|2004|1.5k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer
|Journal of Clinical Oncology|2009|643